PharVision Advisers’s Vale VALE Stock Holding History

PharVision Advisers’s Portfolio VALE Stock Details VALE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-26,023	Closed	-$339K	–	624
2025 Q4	$339K	Buy	26,023 +13,762	+112%	+$167K	0.17%	212
2025 Q3	$133K	Buy	+12,261	New	+$125K	0.07%	588

Other funds holding VALE

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PharVision Advisers's VALE Position: Q1 2026 in Review

PharVision Advisers sold out of Vale (VALE) in Q1 2026, closing a stake of 26,023 shares — an estimated $339K sold.

PharVision Advisers first reported a position in VALE in Q3 2025 and held it in 2 quarters. The position peaked at $339K in Q4 2025. 553 funds tracked by Wall St. Rank hold VALE as of Q1 2026.

PharVision Advisers reported no remaining Vale position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 26,023 Vale shares in Q1 2026, an estimated $339K.
PharVision Advisers first reported a position in Vale in Q3 2025 and held it in 2 quarters.
PharVision Advisers's Vale position peaked at $339K in Q4 2025.
553 funds tracked by Wall St. Rank held Vale as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.